内镜经鼻切除鞍结节脑膜瘤的长期结局
该回顾性研究纳入2008至2024年经内镜经鼻入路治疗的92例鞍结节脑膜瘤患者,随访至少6个月。结果显示Simpson 1级切除率78.3%,视力改善率71.3%,复发率7.6%,仅非Simpson 1级切除与复发或再生长相关。
要点
- 内镜经鼻入路治疗鞍结节脑膜瘤可获得高Simpson 1级切除率和低长期复发率。
- 术前视力障碍者术后71.3%改善,视力下降仅2.5%。
- 非Simpson 1级切除是复发或再生长的独立危险因素。
核心结论
- 内镜经鼻入路是鞍结节脑膜瘤安全有效的首选治疗,可获得高Simpson 1级切除率、低长期复发率和视力改善。
研究设计与样本
- 单中心回顾性研究,纳入2008至2024年经内镜经鼻入路治疗的92例鞍结节脑膜瘤患者,随访至少6个月。
主要发现
- 肿瘤中位最大直径2.0 cm(范围0.4-5.4),WHO I级占97.8%,Simpson 1级切除72例(78.3%)。
- 术前视力障碍的80例中57例(71.3%)改善,2例(2.5%)下降;术后视力检查52例中38例(73.1%)改善,1例下降;视野检查54例中42例(77.8%)改善,3例下降。
- 术后并发症19例(20.7%),包括脑脊液漏12例(13%)和Heubner梗死1例;复发7例(7.6%),中位随访52个月(IQR 24.0-91.4)。
临床怎么用
- 对于鞍结节脑膜瘤,内镜经鼻入路可作为首选治疗方式,追求Simpson 1级切除以降低复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Tuberculum sella meningiomas (TSM) constitute 5% to 10% of intracranial meningiomas and pose surgical challenges because of their proximity to critical neurovascular structures and the optic chiasm. We aimed to evaluate the long-term efficacy of the endoscopic endonasal approach (EEA) for TSMs at a university skull base center. METHODS: A retrospective study of patients with TSM treated using EEA between 2008 and 2024 with a minimum 6 months of follow-up. Clinical outcomes, including the extent of resection, visual outcomes, complications, and recurrence rates, were evaluated. RESULTS: The 92 patients were predominantly female (82.6%), with a median age of 58.3 (range 27.5-82.1) years. Eighteen patients (19.6%) had multiple meningiomas, and 10 (10.9%) were treated for recurrent TSM. The median maximum diameter of tumor was 2.0 (range 0.4-5.4) cm. Most TSMs were World Health Organization grade I (97.8%). Simpson Grade 1 resection was achieved in 72 cases (78.3%). 57/80 patients (71.3%) with preoperative visual dysfunction reported improvement, and 2 (2.5%) reported decline. Of patients with postoperative testing, the visual acuity improved in 38/52 patients (73.1%) and declined in 1 patient, and visual fields improved in 42/54 patients (77.8%) and declined in 3 patients. Postoperative complications were observed in 19 (20.7%) patients, including 12 (13%) with cerebrospinal fluid leak and 1 Heubner infarct. Seven patients (7.6%) experienced recurrence and the median follow-up was 52 months (IQR 24.0-91.4). On multivariable Cox proportional hazard analysis, only non-Simpson Grade 1 resection (hazard ratio = 22.5, P = .004) was associated with recurrence or regrowth. CONCLUSION: EEA is a safe and effective primary treatment for TSMs, yielding a high Simpson Grade 1 rate, resultantly low long-term recurrence rate, and improved visual outcomes.
引用
- Tang A, Bin-Alamer O, Adida S, et al. Long-Term Outcomes of Endoscopic Endonasal Resection for Tuberculum Sella Meningiomas. Neurosurgery. 2026. PMID: 42820706. doi:10.1227/neu.0000000000004232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。